These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15531279)

  • 1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 2. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 3. History of the cholesterol controversy in Britain.
    Thompson GR
    QJM; 2009 Feb; 102(2):81-6. PubMed ID: 19042967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284
    [No Abstract]   [Full Text] [Related]  

  • 6. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 7. [The IMPROVE-IT trial].
    Menozzi A; Lina D; Urbinati S; Greco C
    G Ital Cardiol (Rome); 2015 Dec; 16(12):667-71. PubMed ID: 26667942
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter].
    Poli A
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739-40. PubMed ID: 26667952
    [No Abstract]   [Full Text] [Related]  

  • 10. [The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints].
    Mascitelli L; Goldstein MR
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739. PubMed ID: 26667950
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins have offered great benefits. 2002.
    Yamamoto A
    Atheroscler Suppl; 2004 Oct; 5(3):35-7. PubMed ID: 15531272
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    Atheroscler Suppl; 2004 Oct; 5(3):51-5. PubMed ID: 15531275
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins: in the beginning.
    Lyons KS; Harbinson M
    J R Coll Physicians Edinb; 2009 Dec; 39(4):362-4. PubMed ID: 20509462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Kandzari DE; Goldschmidt-Clermont PJ
    JAMA; 1999 Feb; 281(5):415; author reply 417-9. PubMed ID: 9952193
    [No Abstract]   [Full Text] [Related]  

  • 15. Lowering plasma cholesterol by raising ldl receptors. 1981.
    Brown MS; Goldstein JL
    Atheroscler Suppl; 2004 Oct; 5(3):57-9. PubMed ID: 15531276
    [No Abstract]   [Full Text] [Related]  

  • 16. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
    Collins R
    Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455
    [No Abstract]   [Full Text] [Related]  

  • 19. Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS.
    Sprecher DL
    Cleve Clin J Med; 2000 Mar; 67(3):169-71. PubMed ID: 10743305
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.
    Strandberg TE; Lehto S; Pyörälä K; Kesäniemi A; Oksa H
    Eur Heart J; 1997 Nov; 18(11):1725-7. PubMed ID: 9402446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.